SEC EDGAR — 8-K filingsUnited States8 October 2026
8-K - X4 Pharmaceuticals, Inc (0001501697) (Filer)
This is an official announcement record
Firsthand records what SEC EDGAR — 8-K filings announced and links to the original. The wording below is theirs, not ours.
Filed: 2026-10-08 AccNo: 0001501697-26-000081 Size: 175 KB Item 1.01: Entry into a Material Definitive Agreement Item 1.02: Termination of a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Read the official announcement
Opens www.sec.gov
More from SEC EDGAR — 8-K filings
- 8-K - Trinity Capital Inc. (0001786108) (Filer)8 October 2026
- 8-K - Bain Capital Private Credit (0001899017) (Filer)8 October 2026
- 8-K - Digital Asset Acquisition Corp. (0002052162) (Filer)8 October 2026
- 8-K - Shimmick Corp (0001887944) (Filer)8 October 2026
- 8-K - SILVER BOW MINING CORP. (0002067674) (Filer)8 October 2026
This content is for informational purposes only and is not financial, investment, tax, or legal advice. Rates, fees, and terms change and may differ from what is shown here; verify current details with the provider before acting. Consider consulting a qualified financial professional about your specific situation.